ZBD(SH:603567) Zheng Quan Zhi Xing·2025-05-26 08:16Core Viewpoint - The company received a shareholder inquiry letter from the China Securities Investor Service Center regarding compliance with disclosure and approval procedures related to a significant transaction that generated substantial profits exceeding regulatory thresholds [1][2][3]. Group 1: Transaction Details - The company reported a financial net gain of 420 million yuan from a transaction, which represents over 50% of the company's audited net profit of 185 million yuan for 2022 [1][3]. - The transaction's total amount was 425 million yuan, and it was noted that the transaction's profit exceeded the regulatory requirement of 5 million yuan [3]. Group 2: Regulatory Compliance Issues - The company faced scrutiny due to a warning letter from the Heilongjiang Securities Regulatory Bureau, which identified non-operational fund occupation by the controlling shareholder amounting to 80 million yuan, returned in February 2024 [2]. - The company failed to timely disclose and seek shareholder approval for the transaction, which was only addressed in a board meeting held on April 1, 2025, with subsequent disclosure on April 2, 2025 [3]. Group 3: Measures for Improvement - The company has implemented a comprehensive review and revision of its information disclosure management system to ensure compliance with standards, processes, and responsibilities [4]. - Internal controls have been strengthened, emphasizing the importance of compliance with disclosure regulations and enhancing the effectiveness of internal governance [5][6]. - The company has initiated training programs for personnel involved in information disclosure to improve their understanding of legal requirements and enhance compliance awareness [6][7].